Showing results (191-200 of 330) with videos related to
Sort By:
Pageof 33
Annals of the ICRP|March 11, 2016
Dose-rate effects in radiation biology and radiation protectionW Rühm, T V Azizova, S D Bouffler, et al.Radiation Research|June 4, 1998
Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationshipsA B Schneider, J Lubin, E Ron, et al.Neuroscience Letters|September 2, 2014
Disruption of lateral olivocochlear neurons with a dopaminergic neurotoxin depresses spontaneous auditory nerve activityColleen G Le Prell, David F Dolan, Larry F Hughes, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1988
Radiation-induced thyroid neoplasms: evidence for familial susceptibility factorsV S Perkel, M H Gail, J Lubin, et al.Journal of the National Cancer Institute|September 1, 1977
Breast neoplasms in women treated with x-rays for acute postpartum mastitisR E Shore, L H Hempelmann, E Kowaluk, et al.Breast Cancer Research and Treatment|May 1, 1991
Endogenous hormones and breast cancer: a prospective cohort studyP G Toniolo, B S Pasternack, R E Shore, et al.Disaster Medicine and Public Health Preparedness|March 16, 2011
Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and NagasakiEvan B Douple, Kiyohiko Mabuchi, Harry M Cullings, et al.International Journal of Cancer|May 15, 2001
A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in womenA Lukanova, P Toniolo, A Akhmedkhanov, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1995
Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal womenA Zeleniuch-Jacquotte, P Toniolo, M Levitz, et al.Clinical Orthopaedics and Related Research|May 13, 1998
Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressivaF Kaplan, J Sawyer, S Connors, et al.Pageof 33